O'Reilly John James 4/A
4/A · NovaBay Pharmaceuticals, Inc. · Filed Feb 1, 2011
Insider Transaction Report
Form 4/AAmended
O'Reilly John James
DirectorSVP Business and Corporate Dev
Transactions
- Award
Option (Right to buy)
2008-09-05+44,400→ 94,400 totalExercise: $1.95From: 2009-09-05Exp: 2019-09-05→ Common Stock (44,400 underlying)
Footnotes (1)
- [F1]Original Form 4 filed on 09/09/2008. The re-reporting of this line item is done to gain access to the filing system. This amendment is filed to add a power of attorney as an exhibit.